Menu Search
Equities

Kanabo Group PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
3WD:FRA

Kanabo Group PLC

Actions
  • Price (EUR)0.0005
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-88.89%
  • Beta4.8383
Data delayed at least 15 minutes, as of Apr 30 2025 07:02 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Kanabo Group plc is a United Kingdom-based patient-focused provider of digital health services and specialist medicines. The Company’s principal activities are the distribution and development of cannabis derived medical and wellness products. The Company operates through two segments: Primary case and Secondary case. Primary case segment is involved in the telepharma services provided by GPS. Secondary case segment is involved in the distribution and development of cannabis-derived medical and wellness products. The Company is focused on the distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for cannabidiol (CBD) consumers. It has conducted research and development (R&D) in order to develop cannabis extract formulas, medical-grade vaporizers and various non-smoking consumption solutions. Its clinical and validation activities, including safety and efficiency tests, are conducted in Israel.

  • Revenue in GBP (TTM)1.14m
  • Net income in GBP-8.18m
  • Incorporated2016
  • Employees17.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.